0001510487-15-000003.txt : 20150804
0001510487-15-000003.hdr.sgml : 20150804
20150804163503
ACCESSION NUMBER: 0001510487-15-000003
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20150804
DATE AS OF CHANGE: 20150804
EFFECTIVENESS DATE: 20150804
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Principia Biopharma Inc.
CENTRAL INDEX KEY: 0001510487
IRS NUMBER: 263487603
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-245075
FILM NUMBER: 151026014
BUSINESS ADDRESS:
STREET 1: 400 EAST JAMIE COURT, SUITE 302
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (650) 416-7700
MAIL ADDRESS:
STREET 1: 400 EAST JAMIE COURT, SUITE 302
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
D
1
primary_doc.xml
X0707
D
LIVE
0001510487
Principia Biopharma Inc.
400 EAST JAMIE COURT, SUITE 302
SOUTH SAN FRANCISCO
CA
CALIFORNIA
94080
(650) 416-7700
DELAWARE
None
None
Corporation
true
MARTIN
BABLER
c/o Principia Biopharma, Inc.
400 East Jamie Court, Suite 302
SOUTH SAN FRANCISCO
CA
CALIFORNIA
94080
Executive Officer
Director
MICHAEL
DYBBS
c/o Principia Biopharma, Inc.
400 East Jamie Court, Suite 302
SOUTH SAN FRANCISCO
CA
CALIFORNIA
94080
Director
SIMEON
GEORGE
c/o Principia Biopharma, Inc.
400 East Jamie Court, Suite 302
SOUTH SAN FRANCISCO
CA
CALIFORNIA
94080
Director
SRINIVAS
AKKARAJU
c/o Principia Biopharma, Inc.
400 East Jamie Court, Suite 302
SOUTH SAN FRANCISCO
CA
CALIFORNIA
94080
Director
PETER
THOMPSON
c/o Principia Biopharma, Inc.
400 East Jamie Court, Suite 302
SOUTH SAN FRANCISCO
CA
CALIFORNIA
94080
Director
NASSIM
USMAN
c/o Principia Biopharma, Inc.
400 East Jamie Court, Suite 302
SOUTH SAN FRANCISCO
CA
CALIFORNIA
94080
Director
LEWIS J.
SHUSTER
c/o Principia Biopharma, Inc.
400 East Jamie Court, Suite 302
SOUTH SAN FRANCISCO
CA
CALIFORNIA
94080
Director
Biotechnology
Decline to Disclose
- 06b
false
2015-07-21
false
true
false
0
15292200
15285151
7049
$15,292,200 of the total offering was comprised of Series B-3 Preferred Stock.
false
13
0
0
0
false
Principia Biopharma Inc.
/s/ Martin Babler
Martin Babler
President & CEO
2015-08-04